Table 1. Binding free energies (kcal/mol) between PBP2x protein and cefuroxime (CES) in the two complexes.
Method | Contribution | Complex | |
PBP2x-R61-CES | PBP2x-A7-CES | ||
MM | ELE | −12.7±3.9 | −24.0±4.9 |
VDW | −41.6±3.3 | −58.1±2.9 | |
INT | 0.0±0.2 | 0.0±1.1 | |
GAS | −54.2±4.9 | −82.1±5.9 | |
PBSA | PBSUR | −5.9±0.3 | −6.1±0.1 |
PBCAL | 42.9±5.9 | 51.7±4.3 | |
PBSOL | 37.0±5.8 | 45.6±4.3 | |
PBELE | 30.2±4.1 | 27.7±2.9 | |
PBTOT | −17.2±4.2 | −36.4±4.9 | |
GBSA | GBSUR | −5.9±0.3 | −6.1±0.1 |
GB | 31.7±3.5 | 39.6±3.6 | |
GBSOL | 25.8±3.4 | 33.5±3.6 | |
GBELE | 19.0±2.0 | 15.6±2.3 | |
GBTOT | −28.4±3.1 | −48.6±3.7 |
ELE, electrostatic interactions; VDW, van der Waals interactions between the fragments; INT, internal energy arising from bond, angle and dihedral terms in the MM force field; GAS, total gas phase energy (sum of ELE, VDW and INT); PBSUR/GBSUR, nonpolar contribution to solvation; PBCAL/GB, the electrostatic contribution to the solvation free energy calculated by PB or GB respectively; PBSOL/GBSOL, sum of nonpolar and polar contributions to solvation; PBELE/GBELE, sum of the electrostatic solvation free energy and MM electrostatic energy; PBTOT/GBTOT, estimated total binding free energy calculated from the terms above.